| RS1555594803 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1555594841 |
BRCA1
|
Health Risk |
Pathogenic |
Breast and/or ovarian cancer, Breast and/or ovarian cancer |
| RS1555594861 |
RAD51C
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS1555594864 |
RAD51C
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group O, Hereditary cancer-predisposing syndrome |
| RS1555594912 |
RAD51C
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS1555594935 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1555594954 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1555594986 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1555596072 |
SLC4A1
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 4, Hereditary spherocytosis type 4 |
| RS1555596165 |
SLC4A1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 4, Hereditary spherocytosis type 4 |
| RS1555596273 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1555596294 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555596315 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555596373 |
BRCA1
|
Health Risk |
Likely pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1555596382 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1555596392 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1555596483 |
SLC4A1
|
Health Risk |
Pathogenic |
— |
| RS1555596484 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1555596638 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS1555596663 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1555596757 |
SLC4A1
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 4, Hereditary spherocytosis type 4 |
| RS1555596758 |
MKS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel syndrome, type 1 |
| RS1555596845 |
MKS1
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 13, Meckel syndrome |
| RS1555596943 |
MKS1
|
Health Risk |
Likely pathogenic |
Joubert syndrome 28, Meckel syndrome |
| RS1555597094 |
RAD51C
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group O, Breast-ovarian cancer |
| RS1555597132 |
RAD51C
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS1555597152 |
BRCA1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555597189 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group O, Hereditary cancer-predisposing syndrome |
| RS1555597195 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1555597214 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS1555597215 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1555597217 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS1555597235 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1555597239 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1555597252 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS1555597309 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1555598460 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS1555598544 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS1555598609 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1555598687 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1555598796 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS1555598800 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1555598802 |
GAA
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type II |
| RS1555598824 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS1555598869 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1555598880 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS1555598888 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS1555599090 |
RAD51C
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS1555599127 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS1555599151 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group O, Hereditary cancer-predisposing syndrome |
| RS1555599171 |
GAA
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type II |
| RS1555599205 |
BRCA1
|
Health Risk |
Likely pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1555599208 |
BRCA1
|
Health Risk |
Pathogenic |
Breast neoplasm, Breast-ovarian cancer |
| RS1555599211 |
DGKE
|
Health Risk |
Pathogenic |
Hemolytic-uremic syndrome, Atypical hemolytic-uremic syndrome |
| RS1555599226 |
BRCA1
|
Health Risk |
Likely pathogenic |
Breast-ovarian cancer, familial |
| RS1555599256 |
RAD51C
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group O, Hereditary cancer-predisposing syndrome |
| RS1555599274 |
RAD51C
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS1555599278 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS1555599281 |
BRCA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1555599288 |
RAD51C
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group O |
| RS1555599292 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555599296 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Breast-ovarian cancer |
| RS1555599412 |
MKS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome 13, Meckel syndrome |
| RS1555599537 |
CACNA1C
|
Health Risk |
Pathogenic |
— |
| RS1555599571 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS1555599586 |
GAA
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type II |
| RS1555599594 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1555599600 |
GAA
|
Health Risk |
Likely pathogenic |
— |
| RS1555599619 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1555599637 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS1555599644 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS1555599667 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS1555599713 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS1555599960 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1555600050 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1555600061 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS1555600070 |
GAA
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type II |
| RS1555600102 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1555600111 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1555600166 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1555600179 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS1555600212 |
GAA
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type II |
| RS1555600214 |
UNC13D
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 3, Familial hemophagocytic lymphohistiocytosis 3 |
| RS1555600235 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS1555600575 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS1555600605 |
SCN4A
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperkalemic periodic paralysis, 7 conditions |
| RS1555600644 |
MKS1
|
Health Risk |
Pathogenic |
Joubert syndrome, Joubert syndrome |
| RS1555600730 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1555600755 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS1555600846 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1555600852 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1555600865 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1555600872 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1555600873 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1555600876 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1555600893 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1555600897 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS1555600909 |
BRCA1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555600921 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS1555601002 |
BRIP1
|
Health Risk |
Pathogenic |
Gastric cancer, Gastric cancer |